Literature DB >> 8470958

Pathogenesis of HSV-1/2 induced vaginitis/vulvitis of the mouse: dependence of lesions on genetic properties of the virus and analysis of pathohistology.

M Fleck1, J Podlech, K Weise, H Müntefering, D Falke.   

Abstract

A scoring system for herpes simplex virus (HSV) induced vaginitis/vulvitis in Balb/c mice was delineated from vaginal infections. Four degrees of vaginitis/vulvitis could be distinguished after infection with suitable strains of HSV despite nearly identical replication rates. The time course of replication, inflammation and pathohistology was compared further. Grade 0 was defined by lack of symptoms despite presence of strong replication, which was detectable at days 3-6. Focal necrotic lesions of the epithelial layer were present containing HSV-specific antigens. DNA could be detected by hybridization only in the outer zone of these areas. At day 6 these zones began to be re-epithelialized. In the vaginal lumen abundant detached epithelial cells and granulocytes were already present by day 2. Grade 1 was macroscopically characterized by a slight inflammation commencing on days 5-6. Replication and antigens in the epithelium were found on days 2-6. HSV-antigens were only detected above the basal membrane, and some infiltration with granulocytes and lymphocytes was observed below the basal membrane at day 4. Grade 2 showed strong redness and inflammation as well as hyperemia. Cellular infiltrates were present in the large antigen containing epithelial lesions and below the basal membrane. From day 4 on, neurons were HSV-antigen and DNA positive and macrophages in the stroma contained antigen. The vulva was also shown to be involved. Grade 3 exhibited prolonged severe hyperemia, and destruction of the epithelium and the stroma with necrosis and infiltration, especially of the vulva. This grading system was shown to depend on certain unknown genetic properties of HSV-strains. Neither thymidine-kinase activity, replication in macrophages, fusion activity of strains nor presence or absence of the Hpa I P-fragment were shown to be of importance for severity of vaginitis/vulvitis. Vaginitis/vulvitis was shown to be an all or none response to HSV independent of the rate of replication. The set of virus genes responsible for neuroinvasiveness after vaginal or i.p. inoculation was found to be different. The time course of replication (mainly days 3-6) and inflammation (days 5-10) indicates that inflammation seems to be a secondary immunological phenomenon induced later by the replication phase of HSV. Our system could be useful for separately testing drugs with antiviral and anti-inflammatory properties.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470958     DOI: 10.1007/bf01316883

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Genital herpesvirus hominis infection in mice. I. Development of an experimental model.

Authors:  J C Overall; E R Kern; R L Schlitzer; S B Friedman; L A Glasgow
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains.

Authors:  K E Schneweis; H Forstbauer; M Olbrich; M Tag
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

3.  Kinetics and genetics of herpes simplex virus-induced antibody formation in mice.

Authors:  A Knoblich; J Görtz; V Härle-Grupp; D Falke
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

4.  Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and 2. II. Histopathological, immunohistochemical and in situ hybridization studies.

Authors:  H Wiegand; H P Dienes; P Schirmacher; J Podlech; K Bohl; M Bohle; D Neumann-Haefelin; D Falke
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Isolation and characterisation of herpes simplex virus type 1 mutants which fail to induce dUTPase activity.

Authors:  F B Fisher; V G Preston
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

6.  Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae.

Authors:  N B Kiviat; J A Paavonen; P Wølner-Hanssen; C W Critchlow; W E Stamm; J Douglas; D A Eschenbach; L A Corey; K K Holmes
Journal:  Hum Pathol       Date:  1990-08       Impact factor: 3.466

7.  Importance of the HpaI-P sequence for herpes simplex virus-1 replication in the adrenal glands.

Authors:  E Peles; H Rosen; G Darai; A Rösen-Wolff; Y Becker
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

8.  Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I. Virological studies.

Authors:  J Podlech; K Weise; D Falke
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

9.  Pathogenesis of zosteriform spread of herpes simplex virus in the mouse.

Authors:  W A Blyth; D A Harbour; T J Hill
Journal:  J Gen Virol       Date:  1984-09       Impact factor: 3.891

10.  Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus.

Authors:  A S Yeager; A M Arvin
Journal:  Pediatrics       Date:  1984-02       Impact factor: 7.124

View more
  7 in total

1.  Replication of herpes simplex virus type 1 and 2 in the medulla of the adrenal gland after vaginal infection of mice.

Authors:  J Podlech; F Hengerer; M Fleck; I Walev; D Falke
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Correlation of virus replication, cytokine (TNF-alpha and IL-1) producing cells, neuronal necrosis and inflammation after intranasal infection of mice with herpes simplex virus strains of different virulence.

Authors:  I Walev; H P Dienes; J Bohl; J Podlech; D Falke
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice.

Authors:  M Fleck; J Podlech; K Weise; D Falke
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

4.  Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites.

Authors:  Margaret B Parr; Earl L Parr
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

5.  Asymptomatic vaginal herpes simplex virus infections in mice: virology and pathohistology.

Authors:  J Podlech; F Hengerer; M Fleck; K Eray
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  A caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goats.

Authors:  Mariarosaria Marinaro; Giovanni Rezza; Giuseppe Del Giudice; Valeriana Colao; Elvira Tarsitano; Michele Camero; Michele Losurdo; Canio Buonavoglia; Maria Tempesta
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

7.  Viral Spread to Enteric Neurons Links Genital HSV-1 Infection to Toxic Megacolon and Lethality.

Authors:  William Khoury-Hanold; Brian Yordy; Philip Kong; Yong Kong; William Ge; Klara Szigeti-Buck; Alexandra Ralevski; Tamas L Horvath; Akiko Iwasaki
Journal:  Cell Host Microbe       Date:  2016-06-08       Impact factor: 21.023

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.